CONFLICT OF INTEREST
SOB
DL has received consultancy fees and/or honoraria from Amryt, Sanofi and Aegerion. LD has received consultancy fees and/or honoraria from Amgen, Akcea, Amryt, Pfizer, SOBI, Aurora Biopharma and Sanofi. SOB is an employee of Amryt Pharmaceuticals DAC. MA has received consultancy fees and/or honoraria from Akcea/Ionis, Alfasigma, Amgen, Amryt, Daichi‐Sankyo, Novartis, Pfizer, Regeneron, Sanofi.